Comparison of parathyroid hormone kinetics in endoscopic thyroidectomy via bilateral areola with open thyroidectomy

What Was Tested

Researchers studied Parathyroid Hormone (PTH 1-84) in this observational study publication.

In this study, the researchers aimed to compare the kinetics of intact parathyroid hormone (iPTH) during the perioperative period of endoscopic thyroidectomy via bilateral areola approach (ETBAA) in the same period, following a traditional open thyroidectomy approach (OTA).

Who Took Part

PubMed indexes the participants as young adults, adults and middle-aged adults, both men and women.

The researchers conducted a prospective observational study of patients who were undergoing thyroidectomy and level VI clearance.

Patients who had been affected by papillary thyroid cancer (PTC) were stratified into three groups: those eligible for endoscopic treatment (ETBAA); patients who were eligible for ETBAA but had opted for OTA (OTA-L); and patients who were not suitable for endoscopic intervention (OTA-H).

How the Study Was Run

A process for locating parathyroid glands was utilized to stratify gland dissection laboriousness.

In Type A, the gland is firmly fixed to thyroid gland.

This type can be sub-classified into three subtypes.

A1: the parathyroid gland is attached to the inherent thyroid capsule.

A2: the gland is partially embedded in the thyroid gland.

What Was Measured

PubMed files the paper under topics including Endoscopy, Neck Dissection, Nipples, Parathyroid Glands, Parathyroid Hormone, Thyroid Cancer, Papillary and Thyroid Neoplasms.

The authors tagged it with the keywords Central compartment lymph node dissection, Hypocalcemia, Intact PTH (iPTH), Morbidity and Thyroid surgery.

What This Means in Plain Language

This is an observational study of Parathyroid Hormone (PTH 1-84).

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2019 (BMC surgery), a journal based in England.

More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.